Effects of selective 5HT3 antagonist on anorectal function in normal female subjects.

被引：0
|
作者：
Gonlachanvit, S [1 ]
Chen, YH [1 ]
Sun, WM [1 ]
Chey, WD [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
GASTROENTEROLOGY | 2001年 / 120卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
3258
引用
收藏
页码：A643 / A643
页数：1
相关论文
共 50 条
  • [1] Effects of granisetron, a selective 5HT3 receptor antagonist, on ouabain-induced emesis in ferrets
    Endo, T
    Sugawara, J
    Nemoto, M
    Minami, M
    Blower, PR
    RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, 1998, 102 (03) : 227 - 239
  • [2] Hyperglycemia affects anorectal motor and sensory function in normal subjects.
    Sattawatthamrong, Y
    Russo, A
    Fraser, R
    Andrews, J
    Boeckxstaens, G
    Read, NW
    Horowitz, M
    Sun, WM
    GASTROENTEROLOGY, 1996, 110 (04) : A753 - A753
  • [3] EEGRAPHIC AND BEHAVIORAL-EFFECTS OF ONDANSETRON, A 5HT3 ANTAGONIST, IN RABBITS
    BO, P
    MARCHIONI, E
    SORAGNA, D
    MURELLI, R
    SAVOLDI, F
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1993, 17 (05): : 801 - 823
  • [4] MCPP BUT NOT TFMPP IS AN ANTAGONIST AT CARDIAC 5HT3 RECEPTORS
    ROBERTSON, DW
    BLOOMQUIST, W
    WONG, DT
    COHEN, ML
    LIFE SCIENCES, 1992, 50 (08) : 599 - 605
  • [5] Ondansetron, a 5HT3 antagonist, improves Tardive Dyskinesia
    Sirota, P
    Mosheva, T
    Shabtay, H
    Giladi, N
    Korczyn, AD
    BIOLOGICAL PSYCHIATRY, 1999, 45 (08) : 94S - 94S
  • [6] INFLUENCE OF AGE AND GENDER ON THE PHARMACOKINETICS OF ONDANSETRON, A 5HT3 ANTAGONIST
    PRITCHARD, JF
    BRYSON, JC
    KERNODLE, AE
    BENEDETTI, TL
    POWELL, JR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 47 (02) : 161 - 161
  • [7] 5HT3 ANTAGONIST BLOCKS CONTRACTIONS ASSOCIATED WITH ABDOMINAL CRAMPING
    OTTERSON, MF
    LEMING, SC
    MOULDER, J
    ENGELSGIERD, M
    GASTROENTEROLOGY, 1995, 108 (04) : A662 - A662
  • [8] Medium term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea
    Saslow, SB
    Scolapio, JS
    Camilleri, M
    Forstrom, LA
    Thomforde, GM
    Burton, DD
    Rubin, J
    Pitot, HC
    Zinsmeister, AR
    GUT, 1998, 42 (05) : 628 - 634
  • [9] Evidence for selective effect of the 5HT3 antagonist alosetron on amygdala and hippocampal activation in IBS patients.
    Naliboff, BD
    Chang, L
    Mandelkern, M
    Hamm, L
    Mayer, EA
    GASTROENTEROLOGY, 2000, 118 (04) : A81 - A81
  • [10] Treatment of Fibromyalgia with Tropisetron, a 5HT3 Serotonin Antagonist: A Pilot Study
    I. A. Papadopoulos
    P. E. Georgiou
    P. P. Katsimbri
    A. A. Drosos
    Clinical Rheumatology, 2000, 19 : 6 - 8
12345